Indonesia approves Pfizer COVID-19 vaccine for emergency use
JAKARTA, July 15 (Reuters) - Indonesia’s Food and Drug
Agency (BPOM) has approved the Pfizer-BioNTech COVID-19 vaccine
for emergency use in the Southeast Asian nation, the head of the
agency said on Thursday.
Agency head Penny Lukito said the vaccine would be given to
Indonesians aged 12 years and above.
(Reporting by Stanley Widianto: writing by Kate Lamb; Editing
by Ed Davies)
((Kate.Lamb@thomsonreuters.com;))
Recent news on Pfizer
See all newsBrief: Pfizer Gets Tax Penalty Of 12.6 Million Rupees
Trump-Xi state dinner guest list includes SpaceX’s Musk, Nvidia’s Huang and LVMH’s Arnault (updated)
Factbox: Trump-Xi state dinner guest list includes SpaceX’s Musk, Nvidia’s Huang and LVMH’s Arnault
Novartis India hits record high on retina drugs distribution deal, Pfizer brand acquisition
Brief: Pfizer Ltd June-Quarter Net Profit 2.04 Billion Rupees